Impact on respiratory tract infections of heptavalent pneumococcal conjugate vaccine administered at 3, 5 and 11 months of age

BACKGROUND: Medical and public health importance of pneumococcal infections justifies the implementation of measures capable of reducing their incidence and severity, and explains why the recently marketed heptavalent pneumococcal conjugate vaccine (PCV-7) has been widely studied by pediatricians. T...

Descripción completa

Detalles Bibliográficos
Autores principales: Esposito, Susanna, Lizioli, Alessandro, Lastrico, Annalisa, Begliatti, Enrica, Rognoni, Alessandro, Tagliabue, Claudia, Cesati, Laura, Carreri, Vittorio, Principi, Nicola
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2007
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1804265/
https://www.ncbi.nlm.nih.gov/pubmed/17313667
http://dx.doi.org/10.1186/1465-9921-8-12

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1804265/
https://www.ncbi.nlm.nih.gov/pubmed/17313667
http://dx.doi.org/10.1186/1465-9921-8-12

Ejemplares similares